South Korea Capillary Blood Sampling Devices Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Lancets, Micro-Collection Tubes, Warming Devices, and Others), By Application (Blood Glucose Testing, Hematology, Coagulation Testing, and Others), and South Korea Capillary Blood Sampling Devices Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareSouth Korea Capillary Blood Sampling Devices Market Insights Forecasts to 2035
- The South Korea Capillary Blood Sampling Devices Market size is Expected to Grow at a CAGR of around 7.3% from 2025 to 2035
- The South Korea Capillary Blood Sampling Devices Market size is expected to hold a significant Share by 2035
Get more details on this report -
According to a research report published by Spherical Insights & Consulting, the South Korea Capillary Blood Sampling Devices Market is anticipated to grow at a CAGR of 7.3% from 2025 to 2035. The market is driven by rising diabetes prevalence, expanding point-of-care (POC) testing, and wider adoption of home-based monitoring. Technological advances in safety-engineered lancets, low-pain penetration mechanisms, and improved micro-collection systems further support market expansion.
Market Overview
The South Korea market for capillary blood sampling devices is broadly defined as the market for medical devices that capture small amount of blood from capillary beds, typically fingersticks or heel sticks, for diagnostic and monitoring purposes. These devices are commonly used for the management of individuals with diabetes mellitus, hemoglobin levels, cholesterol levels, and other point-of-care diagnostics. The South Korea preferred Capillary Blood Sampling Devices Market is expanding due to a range of factors including the increasing incidence of diabetes, cardiovascular diseases, and diseases related to living unhealthy lifestyles. Demand for patient-friendly, minimally invasive sampling methods and the development of new safety lancets and adjustable depth lancers have all contributed to increasing uptake of these products. In addition, South Korea's thriving healthcare system, increasing awareness of home-based remote monitoring, and government support initiatives that promote chronic disease management are creating market opportunities and demand in excess of expectations through 2035.
Report Coverage
This research report categorizes the market for the South Korea capillary blood sampling devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea capillary blood sampling devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea capillary blood sampling devices market.
South Korea Capillary Blood Sampling Devices Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 7.3% |
Historical Data for: | 2020-2023 |
No. of Pages: | 210 |
Tables, Charts & Figures: | 121 |
Segments covered: | By Product Type, By Application |
Companies covered:: | Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific, Medtronic, Siemens Healthineers, Danaher Corporation, PerkinElmer, Bio Rad Laboratories, Others |
Pitfalls & Challenges: | COVID-19 Impact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The South Korea Capillary Blood Sampling Devices Market is driven by increase in the incidence of conditions such as diabetes and lifestyle related diseases that have called for increased frequencies of blood glucose monitoring. Technological developments in safety lancets and other lancing devices, increasing awareness surrounding the early detection of disease, supportive healthcare infrastructure and the movement towards home-based care are all contributing to further adoption in the market.
Restraining Factors
The South Korea capillary blood sampling devices market is constrained due to device costs, stringent regulatory procedures, and concerns about pain or discomfort based on the manufacturer's sampling device protocol. Limited reimbursement guidelines and the availability of other testing alternatives hinder full usage and market growth also.
Market Segmentation
The South Korea capillary blood sampling devices market share is classified into product type and application.
- The lancets segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea capillary blood sampling devices market is segmented by product type into lancets, micro-collection tubes, warming devices, and others. Among these, the lancets segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This share is mainly due to their use as blood glucose testing and also their availability. Micro-collection tubes are also becoming more popular due to their increasing usage in hematology and coagulation testing with warming devices and others for more specialized clinical applications.
- The blood glucose testing segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea capillary blood sampling devices market is segmented by application into blood glucose testing, hematology, coagulation testing, and others. Among these, the blood glucose testing segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to increasing prevalence of diabetes, a greater shift toward home testing, and increased recognition of the importance of regimen monitoring. Hematology and coagulation tests will also have future stable growth with increased diagnostic needs in hospitals and clinics.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea capillary blood sampling devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Roche Diagnostics
- Abbott Laboratories
- Becton, Dickinson and Company
- Thermo Fisher Scientific
- Medtronic
- Siemens Healthineers
- Danaher Corporation
- PerkinElmer
- Bio-Rad Laboratories
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea capillary blood sampling devices market based on the below-mentioned segments:
South Korea Capillary Blood Sampling Devices Market, By Product Type
- Lancets
- Micro-Collection Tubes
- Warming Devices
- Others
South Korea Capillary Blood Sampling Devices Market, By Application
- Blood Glucose Testing
- Hematology
- Coagulation Testing
- Others
Frequently Asked Questions (FAQ)
-
1. What is the South Korea Capillary Blood Sampling Devices Market?The South Korea Capillary Blood Sampling Devices Market refers to medical devices used for collecting small blood samples from capillary beds, usually via fingersticks or heel sticks, for diagnostic purposes such as blood glucose, hemoglobin, cholesterol, and coagulation testing.
-
2. What is the market growth outlook for 2025–2035?The South Korea Capillary Blood Sampling Devices Market is projected to grow at a CAGR of 7.3% between 2025 and 2035, driven by increasing diabetes prevalence, point-of-care testing adoption, and rising demand for home-based monitoring solutions.
-
3. Which product type holds the largest market share?Among product types, lancets held the largest share in 2024 and are expected to maintain dominance due to their widespread use in blood glucose monitoring and broad availability. Micro-collection tubes and warming devices are also witnessing growing adoption.
-
4. Which application segment is expected to dominate?The blood glucose testing segment dominated the market in 2024 and is projected to grow significantly during the forecast period, primarily due to the rising incidence of diabetes and the shift toward frequent home-based testing.
-
5. What are the key drivers of market growth?Market growth is fueled by the increasing incidence of diabetes and lifestyle-related diseases, technological advancements in lancets and micro-collection systems, government support for chronic disease management, and growing awareness of early disease detection.
-
6. Who are the major players in the South Korea Capillary Blood Sampling Devices Market?Key companies active in the market include Roche Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific, Medtronic, Siemens Healthineers, Danaher Corporation, PerkinElmer, and Bio-Rad Laboratories, among others.
Need help to buy this report?